Literature DB >> 25523109

The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment.

S Butenas1, K G Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25523109      PMCID： PMC4348199          DOI： 10.1111/jth.12812

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  13 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?

Authors:  Henri M H Spronk; Arne W J H Dielis; Marina Panova-Noeva; René van Oerle; José W P Govers-Riemslag; Karly Hamulyák; Anna Falanga; Hugo Ten Cate
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

3.  Blood clotting in minimally altered whole blood.

Authors:  M D Rand; J B Lock; C van't Veer; D P Gaffney; K G Mann
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

4.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).

Authors:  K Fujikawa; M E Legaz; H Kato; E W Davie
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

5.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

Authors:  K Naito; K Fujikawa
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

6.  Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.

Authors:  Joost J van Veen; Alex Gatt; Peter C Cooper; Steven Kitchen; Annette E Bowyer; Mike Makris
Journal:  Blood Coagul Fibrinolysis       Date:  2008-04       Impact factor: 1.276

7.  Factor XIa and tissue factor activity in patients with coronary artery disease.

Authors:  Saulius Butenas; Anetta Undas; Matthew T Gissel; Konstanty Szuldrzynski; Krzysztof Zmudka; Kenneth G Mann
Journal:  Thromb Haemost       Date:  2008-01       Impact factor: 5.249

8.  Blood coagulation in hemophilia A and hemophilia C.

Authors:  K M Cawthern; C van 't Veer; J B Lock; M E DiLorenzo; R F Branda; K G Mann
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

9.  Citrate anticoagulation and the dynamics of thrombin generation.

Authors:  K G Mann; M F Whelihan; S Butenas; T Orfeo
Journal:  J Thromb Haemost       Date:  2007-10       Impact factor: 5.824

10.  Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.

Authors:  W A Wuillemin; M Minnema; J C Meijers; D Roem; A J Eerenberg; J H Nuijens; H ten Cate; C E Hack
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113
View more
  3 in total

Review 1.  In microfluidico: Recreating in vivo hemodynamics using miniaturized devices.

Authors:  Shu Zhu; Bradley A Herbig; Ruizhi Li; Thomas V Colace; Ryan W Muthard; Keith B Neeves; Scott L Diamond
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

2.  Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.

Authors:  Pradeep K Singh; Zu-Lin Chen; Katharina Horn; Erin H Norris
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13

Review 3.  Contact Pathway Function During Human Whole Blood Clotting on Procoagulant Surfaces.

Authors:  Shu Zhu; Bradley A Herbig; Xinren Yu; Jason Chen; Scott L Diamond
Journal:  Front Med (Lausanne)       Date:  2018-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.